Mirabegron
Home / API - Under Development / Mirabegron
CAS No.
223673-61-8
Therapeutic Category
- Treatment Of Over Active Bladder
Innovator Brand
MYRBETRIQ
GMP
Not Available
DMF
Not Available
Filed
-
Under Filing
-
Sample
Available
Indication
Myrbetriq® is indicated for the treatment of oab in adult patients with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.